tiprankstipranks
Cogent Biosciences (COGT)
NASDAQ:COGT
US Market
Holding COGT?
Track your performance easily

Cogent Biosciences (COGT) Cash flow

547 Followers

Cogent Biosciences Cash Flow

COGT's free cash flow for Q3 2024 was $-52.26M. For the 2024 fiscal year, COGT's free cash flow was decreased by $-30.92M and operating cash flow was $-51.98M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -191.28M$ -153.62M$ -118.64M$ -58.76M$ -35.85M$ -41.51M
Investing Cash Flow
$ -12.91M$ -97.82M$ -124.72M$ -1.72M$ 8.42M$ 23.16M
Financing Cash Flow
$ 214.43M$ 163.54M$ 163.56M$ 37.98M$ 232.20M$ 108.00K
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 454.29M$ 53.23M$ 141.14M$ 220.94M$ 243.44M$ 38.68M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
-$ 161.82M--$ 25.00M$ 108.00K
Issuance Of Debt
------
Repayment Of Debt
------
Free Cash Flow
$ -192.10M$ -156.42M$ -125.50M$ -60.48M$ -35.53M$ -41.34M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Cogent Biosciences Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis